| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |